Literature DB >> 8030259

Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.

A Apolloni1, T B Sculley.   

Abstract

Peripheral blood lymphocytes, obtained from 94 individuals, were assayed for the presence and type of Epstein-Barr virus (EBV) using primers specific for A-type and B-type EBV in the polymerase chain reaction (PCR). Samples from 16 individuals (17%) were negative for EBV sequences. Of the remaining individuals A-type EBV was detected in 35%, B-type in 21%, and both A- and B-type EBV in 27%. Samples of throat washings were also collected from 33 healthy donors and the presence and type of EBV was determined using PCR. EBV was not detected in 12 donors. However, of those who were excreting EBV, A-type EBV was present in 11 donors (52%), B-type in 7 donors (33%), and both A- and B-types in the remaining 3 donors (14%). These results suggest that infection with B-type EBV and coinfections with both A- and B-type EBV are more common than previously thought.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030259     DOI: 10.1006/viro.1994.1422

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.

Authors:  Q Y Yao; D S Croom-Carter; R J Tierney; G Habeshaw; J T Wilde; F G Hill; C Conlon; A B Rickinson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.

Authors:  B M Kerr; N Kienzle; J M Burrows; S Cross; S L Silins; M Buck; E M Benson; B Coupar; D J Moss; T B Sculley
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.

Authors:  J M Brooks; D S Croom-Carter; A M Leese; R J Tierney; G Habeshaw; A B Rickinson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.

Authors:  Nina Orlova; Fred Wang; Mark H Fogg
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

5.  Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.

Authors:  Q Y Yao; R J Tierney; D Croom-Carter; D Dukers; G M Cooper; C J Ellis; M Rowe; A B Rickinson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Epstein-Barr Virus Genomes Reveal Population Structure and Type 1 Association with Endemic Burkitt Lymphoma.

Authors:  Jeffrey A Bailey; Ann M Moormann; Yasin Kaymaz; Cliff I Oduor; Ozkan Aydemir; Micah A Luftig; Juliana A Otieno; John Michael Ong'echa
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

7.  Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.

Authors:  Craig S Miller; Sergei A Avdiushko; Richard J Kryscio; Robert J Danaher; Robert J Jacob
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

8.  Multiple Epstein-Barr virus infections in healthy individuals.

Authors:  Dennis M Walling; Abigail L Brown; Wiguins Etienne; Wendy A Keitel; Paul D Ling
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas.

Authors:  J Friborg; W P Kong; C C Flowers; S L Flowers; Y Sun; K E Foreman; B J Nickoloff; G J Nabel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Epstein-Barr virus DNA is detected in peripheral blood mononuclear cells of EBV-seronegative infants with infectious mononucleosis-like symptoms.

Authors:  Kazufumi Ikuta; Kyoko Saiga; Masanori Deguchi; Takeshi Sairenji
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.